According to Apellis Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -C$0.45 B. In 2023 the company made an earning of -C$0.72 B an increase over its 2022 earnings that were of -C$0.89 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.